EMEA-001198-PIP03-17-M02

Key facts

Invented name
Akynzeo
Active substance
  • Fosnetupitant
  • Palonosetron
Therapeutic area
Other
Decision number
P/0267/2019
PIP number
EMEA-001198-PIP03-17-M02
Pharmaceutical form(s)
  • Powder for concentrate for solution for infusion
  • Concentrate for solution for infusion
Condition(s) / indication(s)
Prevention of chemotherapy-induced nausea and vomiting
Route(s) of administration
Intravenous use
Contact for public enquiries
Helsinn Birex Pharmaceuticals Limited

E-mail: paediatrics-netu@helsinn.com
Tel. +41 9198 51950

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating